a. Percentage of mapped reads detected using MAPQ≥20 compared to the total mapped reads using MAPQ≥10. b. Percentage of ChIP-enriched peaks discovered using MAPQ≥20 compared to the total number of ChIP-enriched peaks using MAPQ≥10.
Supplementary Figure 2:
Concordance of H3K27ac-enriched peaks among biological replicates from KATO-III cells. Replicate 1 and 2 were generated using Nano-ChIPseq, while data from Baek et al. (2016) was created using conventional ChIPseq methods. The total number of mapped reads from replicate 1 and 2 is >10x more than the Baek et al. data 1 , and therefore more peaks were detected in our replicates. Peaks from replicates were merged using BEDTools. Using this approach, we identified 30,734 unique peaks. Percentage of overlapping peaks found in replicates compared to the total number unique peaks was computed.
Supplementary Figure 6:
Biological processes associated with recurrent predicted super-enhancers using GREAT analysis tool. Processes highlighted by black arrows refer to processes observed by both GOrilla (see Results) and GREAT. a. An example of a somatic gain predicted super-enhancer detected in a copy number neutral region. b. FGFR2-associated predicted super-enhancers detected at regions of somatic copy number gain in KATO-III cells. c. A somatic gain predicted super-enhancer detected in a region with copy number gain in T/N980447. d. A highly recurrent somatic gain (H3K27ac) predicted super-enhancer was detected at the CLDN4 locus. This region was not associated with copy number gain.
Supplementary

Supplementary Figure 9:
Long-range interactions between a predicted superenhancer (black rectangle) at TM4SF1 locus and the TM4SF4 promoter detected in OCUM-1 cells using Capture-C technology. The bottom track indicates the summarized interactions from the capture point #17.
Supplementary Figure 10 : Capture-C interaction profiles. a. Interactions from the EHBP1 predicted super-enhancer (black rectangle) to promoters of TMEM1 and EHBP1 genes. The predicted super-enhancer was detected in OCUM-1 cells, showed somatic gain in primary tumor T20020720 and is associated with up-regulated expression of TMEM1 and EBHP1. b. Interactions from a predicted super-enhancer (black rectangle) at the YWHAZ locus to the promoter of YWHAZ. The predicted super-enhancer was detected in SNU16 cells, showed somatic gain in the primary tumor sample T990275 and is associated with up-regulated expression of YWHAZ. Figure 11: 4C interaction profiles. a. Example of a somatic gain predicted super-enhancer at the ELF3 locus and interactions with neighbouring genes, such as ELF3, RNPEP, ARL8A and LMOD1. Somatic gain activity is associated with up-regulation of ELF3 in primary GCs. Interactions (Q<0.05, r3Cseq) were detected in OCUM-1 cells using 4C. The 4C signal plot (in units of RPM) was generated using the Basic4CSeq package. Two constituent enhancers, e3 and e4 were deleted independently in OCUM-1 cells using CRISPR/Cas9 genome editing technology. b. Long-range interactions between a predicted super-enhancer at KLF5 locus and the KLF5 promoter were detected in OCUM-1 cells. Somatic gain activity in the primary tumor (T76629543) is associated with up-regulation of KLF5 expression in the matched sample. c. Interactions of a predicted super-enhancer at the CABLES1 locus to neighbouring noncoding regions and promoters of genes, including CABLES1 and RIOK3. 
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e1-5'-1 CACCgCCCCATGTCCCCATACAGGC e1-5'-2 AAACGCCTGTATGGGGACATGGGGc e1-3'-1 CACCGGCACACCAGGCAGGATTCC e1-3'-2 AAACGGAATCCTGCCTGGTGTGCC e2-5'-1 CACCgCGGGACTCAGACCTTAGTCA e2-5'-2 AAACTGACTAAGGTCTGAGTCCCGc e2-3'-1 CACCGAGGATTTCTTAAGCCCAGA e2-3'-2 AAACTCTGGGCTTAAGAAATCCTC e3-5'-1 CACCgTGAGGGAGGATAGGCGGGCC e3-5'-2 AAACGGCCCGCCTATCCTCCCTCAc e3-3'-1 CACCgCACCTAGAGGCCTGCTTTAG e3-3'-2 AAACCTAAAGCAGGCCTCTAGGTGc e4-5'-1 CACCGAAGAGAACTCCACCGGGTG e4-5'-2 AAACCACCCGGTGGAGTTCTCTTC e4-3'-1 CACCgCAGACATGACCTAGGTTCCC e4-3'-2 AAACGGGAACCTAGGTCATGTCTGc Determine deletion of enhancer (PCR) e1-5'-F GCCTTCCCTTCCTGATGTC e1-3'-R TAATGGCAAGACTGGTATCCAC e2-5'-F CTTGTGGTACTGTTCCCAGAC e2-3'-R CAGCCTGGGAAGCATATTGA e3-5'-F CTGGGTTCCCACCTGATAAT e3-3'-R GATGAAATCCAAGTCATTGTGTCC e4-5'-F CTTCTGGGTTCAAGTGAGTCT e4-3'-R CATGAGCAAAGGTCCTCCTAC Determine retention of enhancer after targeting (qPCR) e1-int-F CAGTAGGTACACCTGGCAATAG e1-int-R ATCCTGCTTCCTCTTGGAATATC e2-int-F CCAGCTTCTTTCCTCTCCTTATC e2-int-R GGTGAAATCCCATCTCCACTAAA e3-int-F ATCCAGACACACCTGTAGGA e3-int-R CAGAACAAAGTCCAGAGAGAGG e4-int-F CCTGCCTCTCTTCTGCTTTC e4-int-R GTTCATGCCCTGCCTTATCT
Supplementary Discussion
Correlation between gene expression and distal predicted regulatory elements
To correlate distal predicted regulatory elements defined by Nano-ChIPseq to gene expression, we identified 80 predicted super-enhancers exhibiting high recurrence across multiple lines (P < 0.0001, empirical test). The same approach was also used to identify highly recurrent predicted typical enhancers. For both predicted super-enhancers and predicted typical enhancers, genes associated with distal regulatory elements exhibited higher expression that randomly selected genes ( Supplementary Fig. 4b ). Comparing the expression of predicted super-enhancer/typical enhancer associated genes revealed higher overall expression levels (in unit of percentile) for predicted super-enhancer associated genes (P = 5.2x10 -3 , one-sided Wilcoxon's rank sum test). These results suggest a positive association between H3K27ac enrichment in predicted super-enhancers and predicted typical enhancers with target gene expression.
Comparisons of primary gastric non-malignant samples to Epigenome Roadmap
To confirm that our non-malignant gastric tissues are indeed reflective of gastric epithelia and not muscle, immune cells etc, we compared the non-malignant gastric H3K27ac profiles from our study to previously published normal gastric profiles and also to stomach smooth muscle profiles 
Associations between copy number alterations and predicted super-enhancers in gastric cancer
We investigated the extent to which recurrent somatic altered predicted superenhancers might be associated with somatic copy number alterations (sCNAs). We computed overlaps between the predicted super-enhancers and copy number information from the cell lines and primary GCs, using in-house generated Affymetrix SNP6.0 array data.
Our analysis was restricted to regions covered by at least 6 SNP probes per 10 kb (2x higher than the mean genome-wide coverage), to allow regions of sCNA to be confidently identified.
Confirming the reliability of our sCNA analysis, an average of 98% of copy number gains and 82% of copy number losses in our analysis were also reported in Cancer Cell Line Encyclopedia 12 for GC cell lines found in the latter (FU97, KATO-III, MKN7, OCUM-1,
In the cell lines, we found that only 5~6% (± 6% standard deviation) of the predicted super-enhancers were associated with copy number gains (average log2 ratio > 0.6). For example, an FGFR2-associated predicted super-enhancer detected in KATO-III overlapped with copy number gain ( Supplementary Fig. 8b ), suggesting that the observed higher
H3K27ac read density at the locus is potentially driven by regional genomic amplification. On the other hand, the majority of the predicted super-enhancers detected in GC cell lines localized at copy number neutral regions, suggesting that the establishment of predicted super-enhancers is independent of somatic copy number events. This fraction is greater than by random chance (P< 0.01, empirical test)
Similarly, in primary GCs, we were able to compute CNA/SE correlations for 1,748 recurrent somatic gain predicted super-enhancers in 19 primary T/N pairs. We found that a only small fraction of somatic gain predicted super-enhancers (< 2% ± 3% s.d) overlapped with copy number gains ( Supplementary Fig. 8c ), with >90% of somatic gain predicted super-enhancers found in individual T/N pairs are detected within copy number neutral regions ( Supplementary Fig. 8a ). This result suggests that there is no strong association between somatic gain of H3K27ac in predicted super-enhancers and copy number changes 13 , and that H3K27ac acquisition at predicted super-enhancers in the tumor samples are likely driven by mechanisms separate from copy number alteration.
